How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

<p>Abstract</p> <p>Background</p> <p>Germline <it>BRCA1</it> and <it>BRCA2</it> mutation testing offered shortly after a breast cancer diagnosis to inform women’s treatment choices - treatment-focused genetic testing ‘TFGT’ - has entered clinical...

Full description

Bibliographic Details
Main Authors: Watts Kaaren J, Meiser Bettina, Mitchell Gillian, Kirk Judy, Saunders Christobel, Peate Michelle, Duffy Jessica, Kelly Patrick J, Gleeson Margaret, Barlow-Stewart Kristine, Rahman Belinda, Friedlander Michael, Tucker Kathy
Format: Article
Language:English
Published: BMC 2012-07-01
Series:BMC Cancer
Subjects:
Breast cancer
Genetic testing
<it>BRCA1</it>
<it>BRCA</it>2
Treatment
Clinical practice
Online Access:http://www.biomedcentral.com/1471-2407/12/320

Internet

http://www.biomedcentral.com/1471-2407/12/320

Similar Items